期刊
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31
卷 31, 期 -, 页码 51-72出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev-immunol-032712-100008
关键词
ATP; autophagy; calreticulin; damage-associated molecular patterns; HMGB1; TLR4
类别
资金
- Ligue Nationale contre le Cancer (Equipe Labellisee)
- Agence Nationale pour la Recherche (ANR)
- European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain)
- Institut National du Cancer (INCa)
- Canceropole Ile-de-France
- Fondation Bettencourt-Schueller
- AXA Research Fund
- LabEx Immuno-Oncology
- Paris Alliance of Cancer Research Institutes
Depending on the initiating stimulus, cancer cell death can be immunogenic or nonimmunogenic. Immunogenic cell death (ICD) involves changes in the composition of the cell surface as well as the release of soluble mediators, occurring in a defined temporal sequence. Such signals operate on a series of receptors expressed by dendritic cells to stimulate the presentation of tumor antigens to T cells. We postulate that ICD constitutes a prominent pathway for the activation of the immune system against cancer, which in turn determines the long-term success of anticancer therapies. Hence, suboptimal regimens (failing to induce ICD), selective alterations in cancer cells (preventing the emission of immunogenic signals during ICD), or defects in immune effectors (abolishing the perception of ICD by the immune system) can all contribute to therapeutic failure. We surmise that ICD and its subversion by pathogens also play major roles in antiviral immune responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据